Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study

Por Sanchorawala, Vaishali, Quillen, Karen, Sloan, J. Mark, Andrea, Nancy T., Seldin, David C.
Publicado em 2011

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Por Cibeira, Maria Teresa, Sanchorawala, Vaishali, Seldin, David C., Quillen, Karen, Berk, John L., Dember, Laura M., Segal, Adam, Ruberg, Frederick, Meier-Ewert, Hans, Andrea, Nancy T., Sloan, J. Mark, Finn, Kathleen T., Doros, Gheorghe, Blade, Joan, Skinner, Martha
Publicado em 2011